Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haibo Ding

Showing results (131-140 of 152) with videos related to

Pageof 16
Sort By:
Frontiers in Cellular and Infection Microbiology|February 4, 2026
Combining degree centrality and betweenness centrality of molecular networks can effectively pinpoint individuals at high risk of HIV transmission within the networkWen Gan, Bin Zhao, Wei Song, et al.
AIDS (London, England)|July 22, 2022
Antiretroviral therapy initiation within 7 and 8-30 days post-HIV diagnosis demonstrates similar benefits in resource-limited settingsBin Zhao, Haibo Ding, Wei Song, et al.
Frontiers in Immunology|October 27, 2018
Expression of the Inhibitory Receptor TIGIT Is Up-Regulated Specifically on NK Cells With CD226 Activating Receptor From HIV-Infected IndividualsXiaowan Yin, Tingting Liu, Zhuo Wang, et al.
Frontiers in Medicine|October 2, 2025
Prediction of obstructive coronary artery disease in people living with HIV: value of machine learning incorporating HIV-specific factorsHui Liu, Haibo Ding, Yue Zheng, et al.
The Lancet Regional Health. Western Pacific|September 30, 2021
Development and external validation of a prognostic model for survival of people living with HIV/AIDS initiating antiretroviral therapyJunfeng Wang, Tanwei Yuan, Haibo Ding, et al.
ACS Nano|September 13, 2024
Artificial Meshed Vessel-Induced Dimensional Breaking Growth of Human Brain Organoids and Multiregional AssembloidsLei Xu, Haibo Ding, Shanshan Wu, et al.
International Journal of Surgery (London, England)|January 7, 2025
Safety and clinical efficacy of neoadjuvant chemoradiation therapy with immunotherapy for organ preservation in ultra-low rectal cancer: preliminary results of the CHOICE-I trial: a prospective cohort studyLeqi Zhou, Guanyu Yu, Yuxin Shen, et al.
Current HIV Research|February 19, 2019
The Per-1 Short Isoform Inhibits de novo HIV-1 Transcription in Resting CD4+ T-cellsLi Zhao, Mei Liu, Jiayue Ouyang, et al.
Frontiers in Immunology|August 9, 2021
Rapid Clinical Progression and Its Correlates Among Acute HIV Infected Men Who Have Sex With Men in China： Findings From a 5-Year Multicenter Prospective Cohort StudyJing Zhang, Xiao-Jie Huang, Wei-Ming Tang, et al.
Frontiers in Immunology|October 6, 2017
NKG2C<sup>+</sup>NKG2A<sup>-</sup> Natural Killer Cells are Associated with a Lower Viral Set Point and may Predict Disease Progression in Individuals with Primary HIV InfectionMeichen Ma, Zhuo Wang, Xi Chen, et al.
Pageof 16

Showing results (131-140 of 152) with videos related to

Sort By:
Pageof 16
Frontiers in Cellular and Infection Microbiology|February 4, 2026
Combining degree centrality and betweenness centrality of molecular networks can effectively pinpoint individuals at high risk of HIV transmission within the networkWen Gan, Bin Zhao, Wei Song, et al.
AIDS (London, England)|July 22, 2022
Antiretroviral therapy initiation within 7 and 8-30 days post-HIV diagnosis demonstrates similar benefits in resource-limited settingsBin Zhao, Haibo Ding, Wei Song, et al.
Frontiers in Immunology|October 27, 2018
Expression of the Inhibitory Receptor TIGIT Is Up-Regulated Specifically on NK Cells With CD226 Activating Receptor From HIV-Infected IndividualsXiaowan Yin, Tingting Liu, Zhuo Wang, et al.
Frontiers in Medicine|October 2, 2025
Prediction of obstructive coronary artery disease in people living with HIV: value of machine learning incorporating HIV-specific factorsHui Liu, Haibo Ding, Yue Zheng, et al.
The Lancet Regional Health. Western Pacific|September 30, 2021
Development and external validation of a prognostic model for survival of people living with HIV/AIDS initiating antiretroviral therapyJunfeng Wang, Tanwei Yuan, Haibo Ding, et al.
ACS Nano|September 13, 2024
Artificial Meshed Vessel-Induced Dimensional Breaking Growth of Human Brain Organoids and Multiregional AssembloidsLei Xu, Haibo Ding, Shanshan Wu, et al.
International Journal of Surgery (London, England)|January 7, 2025
Safety and clinical efficacy of neoadjuvant chemoradiation therapy with immunotherapy for organ preservation in ultra-low rectal cancer: preliminary results of the CHOICE-I trial: a prospective cohort studyLeqi Zhou, Guanyu Yu, Yuxin Shen, et al.
Current HIV Research|February 19, 2019
The Per-1 Short Isoform Inhibits de novo HIV-1 Transcription in Resting CD4+ T-cellsLi Zhao, Mei Liu, Jiayue Ouyang, et al.
Frontiers in Immunology|August 9, 2021
Rapid Clinical Progression and Its Correlates Among Acute HIV Infected Men Who Have Sex With Men in China： Findings From a 5-Year Multicenter Prospective Cohort StudyJing Zhang, Xiao-Jie Huang, Wei-Ming Tang, et al.
Frontiers in Immunology|October 6, 2017
NKG2C<sup>+</sup>NKG2A<sup>-</sup> Natural Killer Cells are Associated with a Lower Viral Set Point and may Predict Disease Progression in Individuals with Primary HIV InfectionMeichen Ma, Zhuo Wang, Xi Chen, et al.
Pageof 16